Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2 - 05/05/21
Doi : 10.1016/j.jaci.2021.03.011
Yorissa Padayachee, MBChB a, Tasnim Shahridan Faiez, MSc b, Aran Singanayagam, PhD b, Patrick Mallia, PhD b, Sebastian Lennox Johnston, PhD b, ⁎ 
a Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom
b National Heart and Lung Institute, Imperial College London, London, United Kingdom
∗Corresponding author: Sebastian Lennox Johnston, PhD, National Heart and Lung Institute, Department of Respiratory Medicine, Imperial College London, London W21PG, UK.National Heart and Lung InstituteDepartment of Respiratory MedicineImperial College LondonLondonW21PGUK
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Key words : Severe acute respiratory syndrome coronavirus-2, COVID-19, rhinoviruses, asthma, asthma exacerbation, interferons
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| S.L.J. is the Asthma UK Clinical Chair (grant no. CH11SJ) and a National Institute of Health Research (NIHR) Emeritus Senior Investigator and is funded in part by European Research Council Advanced Grant (grant no. 788575). This research was supported by the NIHR Imperial Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. |
|
| Disclosure of potential conflict of interest: S. L. Johnston is an author on patents relating to use of inhaled interferons for the treatment of exacerbations of airway disease and is also an author on patents for rhinovirus vaccines. The rest of the authors declare that they have no relevant conflicts of interest. |
Crown Copyright © 2021
Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 5
P. 1648-1651 - Maggio 2021 Ritorno al numero
Articolo precedente
- New targets in treating granuloma annulare
- Chia-Yu Chu
- IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
- Alberto Utrero-Rico, Javier Ruiz-Hornillos, Cecilia González-Cuadrado, Claudia Geraldine Rita, Berta Almoguera, Pablo Minguez, Antonio Herrero-González, Mario Fernández-Ruiz, Octavio Carretero, Juan Carlos Taracido-Fernández, Rosario López-Rodriguez, Marta Corton, José María Aguado, Luisa María Villar, Carmen Ayuso-García, Estela Paz-Artal, Rocio Laguna-Goya
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.